DraftKings (DKNG) Stock Plunges 10% as Senate Bill and NCAA Lawsuit Strike

Key Takeaways

Table of Contents

Shares of DKNG declined approximately 10% Wednesday, settling near $22.52 with trading volume down 82% from typical levels
Legislative developments in the Senate concerning sports betting rattled investors and sparked a significant selloff
NCAA filed legal action against DraftKings seeking to prevent the company’s use of tournament-related trademarks including “March Madness”
The company previously lowered its 2026 revenue forecast to between $6.5 billion and $6.9 billion, falling short of analyst projections by more than $600 million
Wall Street maintains a “Moderate Buy” rating overall, with the average analyst price target reaching $37.09—significantly above present trading levels

Shares of DraftKings (DKNG) were changing hands around $22.52 during Wednesday’s session, reflecting a decline of approximately 10% for the day.

DraftKings Inc., DKNG

The steep Wednesday decline reflects the convergence of two significant challenges. Market participants reacted negatively to emerging Senate legislation related to sports wagering, while simultaneously the NCAA initiated legal proceedings aimed at preventing the company from utilizing popular tournament branding such as “March Madness.”

The NCAA’s legal action arrives at an especially inopportune moment. Filing occurred during the heart of tournament season—among the most profitable and high-volume windows for sports wagering platforms. Potential restrictions on marketing campaigns or court-ordered limitations could negatively impact promotional strategies and near-term revenue generation.

Trading activity Wednesday registered just north of 2.8 million shares, representing an 82% decline compared to the typical session average of 15.6 million. Such dramatically reduced liquidity can exaggerate price swings in both directions.

This represents the latest setback for DKNG during 2026. Earlier in the year, company leadership projected annual revenue between $6.5 billion and $6.9 billion, figures that disappointed analysts by exceeding $600 million below consensus forecasts. The equity experienced a mid-teen percentage decline following that disclosure and has faced ongoing headwinds since.

Revenue Outlook Disappoints Following Impressive 2025 Performance

The underwhelming guidance proved particularly disappointing considering the strength demonstrated in Q4 2025 results. Revenue reached approximately $1.99 billion, representing 43% year-over-year expansion. Adjusted EBITDA surged more than threefold to around $620 million annually, and the organization achieved positive net income for its first time ever.

DraftKings accomplished what the market had long anticipated—only to temper future expectations. This mixed messaging fundamentally altered the growth story entering 2026.

The stock currently trades considerably beneath both its 50-day moving average of $26.39 and 200-day moving average of $32.01, demonstrating the persistent downward pressure following the guidance revision.

Regarding competitive positioning, DraftKings has pursued an aggressive pricing approach. Analysis conducted during March Madness revealed DKNG providing the most attractive average vigorish among leading operators on moneyline wagers and total bets. While this strategy maintains customer engagement, it simultaneously compresses profit margins.

Wall Street Remains Optimistic Despite Lower Price Targets

The analyst community continues supporting the equity. Twenty-five analysts assign Buy ratings, five recommend Hold, and two rate it Sell. The consensus 12-month price objective stands at $37.09—representing upside exceeding 60% from Wednesday’s trading level.

Mizuho reduced its target from $46 to $44 while preserving an “outperform” designation. Stifel lowered its estimate from $44 to $40, retaining a “buy” recommendation. Jefferies maintains a $46 objective. Wells Fargo confirmed its “overweight” stance.

Regarding insider activity, Director Harry Sloan acquired 100,000 shares at $21.85 during February—a $2.185 million investment signaling confidence that shares were undervalued. That transaction currently trades approximately even with present market prices.

Insiders collectively divested roughly 549,495 shares throughout the past 90 days, though they continue controlling 47.08% of outstanding equity. Institutional investors hold 37.7% of shares.

The stock trades near its 52-week bottom, with market capitalization hovering around $10.63 billion and a beta coefficient of 1.67.

✨ Limited Time Offer